Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhGH for Rehabilitation in Traumatic Brain Injury
NCT00766038Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Sep 2008
- Primary completion
- Jun 2013
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in traumatic brain injury (TBI) comparing rhGH with Placebo (2 arms). Primary endpoint: Functional Outcome 6 Months After Injury. Started Sep 2008; status: completed.
02
Drugs
somatropin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT00766038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00766038.